Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
-
New drug aims to tame lupus kidney disease in landmark trial
Disease control Not yet recruitingThis study tests a new medicine, SIM0278, in 60 adults with active lupus nephritis, a serious kidney complication of lupus. Participants will receive either SIM0278 or a placebo, along with standard therapy, to see if the drug helps improve kidney function over 52 weeks. The goal…
Phase: PHASE2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 17, 2026 09:26 UTC
-
Healthy volunteers to test new remdesivir formulation
Knowledge-focused Not yet recruitingThis study will compare two different versions of an oral remdesivir drug in 48 healthy Chinese adults. Participants will receive both forms at different times to see how the body absorbs and processes each one. The goal is to understand if the new formulation works similarly to …
Phase: PHASE1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 09:21 UTC